Hopp til innhold
NHI.no
Annonse

Jernmangelanemi: Prognosen

Innhold i artikkelen

Forløpet avhenger helt av årsaken til blodmangelen. Som oftest er jernmangelanemi i seg selv lett å behandle med ekstra tilførsel av jern. Selve jernmangelanemien gir få komplikasjoner utover plagsomme symptomer. Imidlertid vil en svært lav blodprosent (alvorlig anemi) disponere for uregelmessig hjerteaksjon, angina og hjerteinfarkt blant de eldste. Ellers er prognosen avhengig av underliggende sykdom som er årsak til jernmangelen.

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Jernmangelanemi . Referanselisten for dette dokumentet vises nedenfor

  1. Dahlerup J, Moum B, Lindgren S. Järnbrist och järnbristanemi är globala hälsoproblem. Läkartidningen 2015. pmid:25756711 PubMed
  2. Hemoglobin, B. Nasjonal brukerhåndbok i Medisinsk Biokjemi. Publisert 13.12.2018. Versjon 2.0. www.prosedyrer.no
  3. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015 May 7;372(19):1832-43. PMID: 25946282 PubMed
  4. Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Physician 2007; 75: 671-8. PubMed
  5. Borch-Iohnsen B, Sandstad B, Asberg A. Iron status among 3005 women aged 20-55 years in Central Norway: the Nord-Trøndelag Health Study (the HUNT study). Scand J Clin Lab Invest 2005; 65: 45-54. pmid:15859026 PubMed
  6. Hay G, Sandstad B, Whitelaw A, Borch-Iohnsen B. Iron status in a group of Norwegian children aged 6-24 months. Acta Paediatr 2004; 95: 592-8. pmid:15174778 PubMed
  7. Nordic Nutrition Recommendations 2012. Integrating nutrition and physical activity. Utgitt 11.03.2014. www.norden.org
  8. WHO Global Database on Anaemia. Worldwide Prevalence of Anaemia 1993–2005. Geneva, Switzerland: World Health Organization; 2008.
  9. Hagve TA, Lilleholt K, Svendsen M. Jernmangelanemi – tolking av biokjemiske og hematologiske funn. Tidsskr Nor Laegeforen 2013; 133: 161-4. Pmid: 23344599.
  10. Heath AL and Fairweather-Tait SJ. Clinical implications of changes in the modern diet: iron intake, absorption and status. Best Pract Res Clin Haematol 2002; 15: 225-41. PubMed
  11. Haas JD, Brownlie T IV. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 2001; 131(2 suppl): 676-88.
  12. Algarin C, Peirano P, Garrido M, Pizarro F, Lozoff B. Iron deficiency anemia in infancy: long-lasting effects on auditory and visual system functioning. Pediatr Res 2003; 53: 217-23. PubMed
  13. Verdon F, Burnand B, Stubi CL, Bonard C, Graff M, Michaud A, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ 2003; 326: 1124. British Medical Journal
  14. Hershko C, Hoffbrand AV, Keret D et al. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Haematologica 2005; 90: 585-95. PubMed
  15. Lam JR, Schneider JL, Quesenberry CP, Corley DA . Proton pump inhibitor and histamine-2 receptor antagonist use and iron deficiency. Gastroenterology 2016. pmid:27890768 PubMed
  16. Ning S, Zeller MP. Management of iron deficiency. Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):315-322. doi: 10.1182/hematology.2019000034. PMID: 31808874 PubMed
  17. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005; 18: 319-32. PubMed
  18. Cook JD. Newer aspects of the diagnosis and treatment of iron deficiency. American Society of Hematology Educational Program Book, 2003: 40-61.
  19. St. Olavs Hospital, medisinsk biokjemi- Analyser og undersøkelser: Jernbelastning. Siden besøkt 13.01.2021 data.stolav.no
  20. Helsedirektoratet. Nasjonal faglig retningslinje for svangerskapsomsorgen. Oslo, 2018
  21. Jacobsen EM, Jacobsen AF, Sun C et al. Anemi og graviditet. Veileder i fødselshjelp. Norsk gynekologisk forening, 2020. Siden besøkt 02.10.2020
  22. Peña-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database of Systematic Reviews 2015, Issue 7. Art. No.: CD004736. DOI: 10.1002/14651858.CD004736.pub5. DOI
  23. Ioannou GN, Rockey DC, Bryson CL, Weiss NS. Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am J Med 2002; 113: 276-80. PubMed
  24. Lee MW, Pourmoraday JS, Laine L. Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2020; Jan 10: Epub. pmid:31972617 PubMed
  25. Holtedahl KA. Use of faecal occult blood tests in symptomatic patients. BMJ 2015; 351: h4256. www.bmj.com
  26. Goddard AF, James MW, McIntyre AS, Scott BB; British Society of Gastroenterology. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60(10):1309-1316. PubMed
  27. Radtke H, Tegtmeier J, Rocker L, Salama A, Kiesewetter H. Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study. Transfusion 2004; 44: 1427-32. PubMed
  28. Gurusamy KS, Nagendran M, Broadhurst JF, Anker SD, Richards T. Iron therapy in anaemic adults without chronic kidney disease. Cochrane Database of Systematic Reviews 2014, Issue 12. Art. No.: CD010640. DOI: 10.1002/14651858.CD010640.pub2 DOI
  29. Schjøtt J. Ulike doseringsanbefalinger for jern. Nor Farmaceut Tidsskr 2009; 117: 21. PubMed
  30. Fernández‐Gaxiola AC, De‐Regil LM. Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women. Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No.: CD009218. DOI: 10.1002/14651858.CD009218.pub3. DOI
  31. Li N, Zhao G, Wu W, et al. The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia A Randomized Clinical Trial. JAMA Netw Open 2020; 3: e2023644. doi:10.1001/jamanetworkopen.2020.23644 DOI
  32. Disler PB, Lynch SR, Charlton RW, Torrance JD, Bothwell TH, Walker RB, et al. The effect of tea on iron absorption. Gut 1975; 16: 193-200. Gut
  33. Rimon E, Kagansky N, Kagansky M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 2005; 118: 1142-7. PubMed
  34. Norsk legemiddelhåndbok. Jern III-verdig til parenteral administrasjon. Sist endret 20.11.2017. Siden besøkt 13.01.2021 www.legemiddelhandboka.no
  35. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: Systematic review and meta-analysis of randomised clinical trials. BMJ 2013; 347: f4822. BMJ (DOI)
  36. Michael B, Coyne DW, Fishbane S, Folkert V, Lynn R, Nissenson AR, et al. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int 2002; 61: 1830-9. PubMed
  37. Statens legemiddelverk. Intravenøse jernpreparater gir risiko for alvorlig overfølsomhetsreaksjon. Publisert 01.11.2013. Siden besøkt 13.01.2021 legemiddelverket.no
  38. Avni T, Bieber A, Grossman A, et al. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015 ;90(1):12-23. PMID: 25572192. PubMed
  39. Goddard AF, James MW, McIntyre AS, et al. Guidelines for the management of iron deficiency anaemia. Gut 2011;60:1309-1316. Gut
  40. Camaschella C. Iron-deficiency anemia. Review article. N Engl J Med 2015; 372: 1832-43. doi:10.1056/NEJMra1401038 DOI
Annonse
Annonse